Search clinical trials for: Lorlatinib

Total 27 results

  • NCT04541706
    Active, not recruiting
    Conditions: Advanced Non-Small Cell Lung Cancer
  • NCT03909971
    Recruiting
    Conditions: Carcinoma, Non-Small-Cell Lung
  • NCT04621188
    Recruiting
    Conditions: Non Small Cell Lung Cancer Metastatic
  • NCT03546894
    Active, not recruiting
    Conditions: Anaplastic Lymphoma Kinase-positive, Carcinoma Non-small-cell Lung
  • NCT04753658
    Recruiting
    Conditions: Neuroblastoma
  • NCT04362072
    Recruiting
    Conditions: Carcinoma, Non-Small-Cell Lung
  • NCT03726333
    Recruiting
    Conditions: Advanced Cancers
  • NCT04647110
    Completed
    Conditions: ALK-positive NSCLC
  • NCT03737994
    Active, not recruiting
    Conditions: Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
  • NCT04800822
    Recruiting
    Conditions: Solid Tumor
  • NCT04127110
    Recruiting
    Conditions: Non Small Cell Lung Cancer
  • NCT02925234
    Recruiting
    Conditions: Cancer, Tumors, Neoplasm, Neoplasia
  • NCT04292119
    Recruiting
    Conditions: Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement, Relapsed Cancer, MET Amplification, Resistant Cancer, NSCLC
  • NCT02927340
    Recruiting
    Conditions: Non-Small Cell Lung Cancer (NSCLC)
  • NCT04541407
    Recruiting
    Conditions: Non Small Cell Lung Cancer, CNS Progression
  • NCT03542305
    Completed
    Conditions: Renal Impairment
  • NCT03052608
    Recruiting
    Conditions: Carcinoma, Non-Small-Cell Lung
  • NCT03107988
    Recruiting
    Conditions: Neuroblastoma
  • NCT03878524
    Recruiting
    Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IIIA Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IV Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma, Ann Arbor Stage IVB Hodgkin Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Castration-Resistant Prostate Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Pancreatic Adenocarcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma, Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Primary Myelofibrosis, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hematologic Malignancy, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Myeloproliferative Neoplasm, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Chronic Myelomonocytic Leukemia, Refractory Hematologic Malignancy, Refractory Hodgkin Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Myelodysplastic Syndrome, Refractory Myelodysplastic/Myeloproliferative Neoplasm, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Primary Myelofibrosis, Refractory Small Lymphocytic Lymphoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8, Stage IIB Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Unresectable Pancreatic Adenocarcinoma
  • NCT03505554
    Recruiting
    Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive
  • NCT04111705
    Recruiting
    Conditions: Non Small Cell Lung Cancer Metastatic
  • NCT03612154
    Recruiting
    Conditions: Nonsmall Cell Lung Cancer
  • NCT03127618
    Approved for marketing
    Conditions:
  • NCT03961997
    Completed
    Conditions: Adult, Drug Interactions, Healthy Volunteers, Humans
  • NCT03178071
    No longer available
    Conditions: Non Small Cell Lung Cancer ALK Positive or ROS1 Positive